Personalized medicine, which considers an individual's genetic makeup, environmental exposures, and lifestyle factors, holds promise for improving TRD outcomes. By integrating toxicological data, clinicians can develop personalized treatment plans that account for potential toxic exposures and metabolic differences, thereby increasing the likelihood of treatment success.
